Used in pharmaceutical research as a beta-adrenergic receptor modulator, particularly investigated for its potential in treating cardiovascular and respiratory conditions. It shows activity in relaxing smooth muscle tissue, making it a candidate for development in asthma therapies and heart-related disorders involving vasoconstriction. Its structure allows for high selectivity toward beta-2 adrenergic receptors, which helps minimize side effects commonly seen with non-selective agonists. Also explored for use in ophthalmic formulations to reduce intraocular pressure due to its vasodilatory and fluid-regulating effects.